Human parainfluenza viruses epidemiology and demographics
|
Human parainfluenza viruses Microchapters |
|
Differentiating Human parainfluenza viruses from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Human parainfluenza viruses epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Human parainfluenza viruses epidemiology and demographics |
|
FDA on Human parainfluenza viruses epidemiology and demographics |
|
CDC on Human parainfluenza viruses epidemiology and demographics |
|
Human parainfluenza viruses epidemiology and demographics in the news |
|
Blogs on Human parainfluenza viruses epidemiology and demographics |
|
Directions to Hospitals Treating Human parainfluenza viruses |
|
Risk calculators and risk factors for Human parainfluenza viruses epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Each of the four HPIVs has different clinical and epidemiologic features. The most distinctive clinical feature of HPIV-1 and HPIV-2 is croup (i.e., laryngotracheobronchitis); HPIV-1 is the leading cause of croup in children, whereas HPIV-2 is less frequently detected. Both HPIV-1 and -2 can cause other upper and lower respiratory tract illnesses. HPIV-3 is more often associated with bronchiolitis and pneumonia. HPIV-4 is infrequently detected, possibly because it is less likely to cause severe disease. The incubation period for HPIVs is generally from 1 to 7 days.